StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > BASHERS NEVER BASH A BAD STOCK

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Dec 03, 2020 12:33am

73 Views

Post# 32024148

RE:BASHERS NEVER BASH A BAD STOCK

Your turn on the prison community computer aye? Boy the things they let you guys do these days.

VerifiedUser123 wrote: Nope only speak the truth. You guys are hilarious. Talking out of both sides of your mouth. 3000 tests a day we'll be doing this, multi dollar valuation that. Now I'm seeing range bound until Arist-dam-otle. My god this better pan out for all of our sakes.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports